The possible revenue growth rate (average) and 2014 Q4This is what Bedrocan 2014 Q3 earning says.
"For the three and nine month period ended October 31, 2014, the Company generated revenues of $493,363 and $1,086,744 respectively"
And the CEO projected that Bedrocan will breakeven at year end -- this represents 1875000$ sales revenue in Q4 2015.
From 493363 to 1875000, it means the company will be 3.8 times of its 2014 Q3 revenue in about 5 Earning Reports.
That is 30% incensement QoQ.
So, the 2014 Q4 could have sales up to 641, 371$, Because 30% is an average incensement, considering the slow start and import limit of 2014, I think 580,000 ~ 600,000$ revenue should be more realistic.